According to CTI BioPharma 's latest financial reports the company's current earnings (TTM) are -$69.24 M. In 2022 the company made an earning of -$93 M an increase over its 2021 earnings that were of -$97.91 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$69.24 M | -25.54% |
2022 | -$93 M | -5.02% |
2021 | -$97.91 M | 86.67% |
2020 | -$52.46 M | 31.05% |
2019 | -$40.03 M | 36.36% |
2018 | -$29.36 M | -28.11% |
2017 | -$40.84 M | -22.89% |
2016 | -$52.96 M | -56.15% |
2015 | -$0.13 B | 28.16% |
2014 | -$94.23 M | 116.37% |
2013 | -$43.55 M | -57.17% |
2012 | -$0.11 B | 62.39% |
2011 | -$62.62 M | -16.23% |
2010 | -$74.76 M | -20.68% |
2009 | -$94.25 M | 22.01% |
2008 | -$77.25 M | -28.59% |
2007 | -$0.11 B | 10.34% |
2006 | -$98.03 M | 118.07% |
2005 | -$44.96 M | -70.71% |
2004 | -$0.16 B | 25.18% |
2003 | -$0.13 B | 21.81% |
2002 | -$0.11 B | 20.55% |
2001 | -$83.49 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Novartis NVS | $9.43 B | -13,731.05% | ๐จ๐ญ Switzerland |
Eli Lilly LLY | $6.55 B | -9,566.63% | ๐บ๐ธ USA |
Amgen AMGN | $7.85 B | -11,444.76% | ๐บ๐ธ USA |
Baxter BAX | -$47 M | -32.12% | ๐บ๐ธ USA |
Incyte INCY | $0.83 B | -1,304.83% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $8.44 B | -12,289.66% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $0.40 B | -684.93% | ๐ฎ๐ฑ Israel |